(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-(4-cyclopropyl-3-hydroxyphenyl)prop-2-en-1-one;(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;4-bromo-2-hydroxybenzoic acid;5-bromo-2-(2-hydroxypropan-2-yl)phenol;(E)-1-[4-(3-ethylphenyl)piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;(E)-4-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]but-3-en-2-one;(E)-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;methyl 4-bromo-2-hydroxybenzoate

C122H142Br3N5O23 — CID 158764426

IUPAC(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-(4-cyclopropyl-3-hydroxyphenyl)prop-2-en-1-one;(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;4-bromo-2-hydroxybenzoic acid;5-bromo-2-(2-hydroxypropan-2-yl)phenol;(E)-1-[4-(3-ethylphenyl)piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;(E)-4-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]but-3-en-2-one;(E)-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;methyl 4-bromo-2-hydroxybenzoate
SMILESCC(=O)/C=C/c1ccc(C(C)(C)O)c(O)c1.CC(C)(O)c1ccc(/C=C/C(=O)N2CCC(c3cccc(CN)c3)CC2)cc1O.CC(C)(O)c1ccc(/C=C/C(=O)O)cc1O.CC(C)(O)c1ccc(Br)cc1O.CCc1cccc(C2CCN(C(=O)/C=C/c3ccc(C(C)(C)O)c(O)c3)CC2)c1.COC(=O)c1ccc(Br)cc1O.NCc1cccc(C2CCN(C(=O)/C=C/c3ccc(C4CC4)c(O)c3)CC2)c1.O=C(O)c1ccc(Br)cc1O
InChIInChI=1S/C25H31NO3.C24H30N2O3.C24H28N2O2.C13H16O3.C12H14O4.C9H11BrO2.C8H7BrO3.C7H5BrO3/c1-4-18-6-5-7-21(16-18)20-12-14-26(15-13-20)24(28)11-9-19-8-10-22(23(27)17-19)25(2,3)29;1-24(2,29)21-8-6-17(15-22(21)27)7-9-23(28)26-12-10-19(11-13-26)20-5-3-4-18(14-20)16-25;25-16-18-2-1-3-21(14-18)19-10-12-26(13-11-19)24(28)9-5-17-4-8-22(20-6-7-20)23(27)15-17;1-9(14)4-5-10-6-7-11(12(15)8-10)13(2,3)16;1-12(2,16)9-5-3-8(7-10(9)13)4-6-11(14)15;1-9(2,12)7-4-3-6(10)5-8(7)11;1-12-8(11)6-3-2-5(9)4-7(6)10;8-4-1-2-5(7(10)11)6(9)3-4/h5-11,16-17,20,27,29H,4,12-15H2,1-3H3;3-9,14-15,19,27,29H,10-13,16,25H2,1-2H3;1-5,8-9,14-15,19-20,27H,6-7,10-13,16,25H2;4-8,15-16H,1-3H3;3-7,13,16H,1-2H3,(H,14,15);3-5,11-12H,1-2H3;2-4,10H,1H3;1-3,9H,(H,10,11)/b11-9+;9-7+;9-5+;5-4+;6-4+;;;
InChIKeyIPBQWYLRESCPDA-MQPMCTMVSA-N
MW2286.20 g/mol
LogP22.36
Rot. Bonds24

About (E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-(4-cyclopropyl-3-hydroxyphenyl)prop-2-en-1-one;(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;4-bromo-2-hydroxybenzoic acid;5-bromo-2-(2-hydroxypropan-2-yl)phenol;(E)-1-[4-(3-ethylphenyl)piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;(E)-4-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]but-3-en-2-one;(E)-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;methyl 4-bromo-2-hydroxybenzoate

(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-(4-cyclopropyl-3-hydroxyphenyl)prop-2-en-1-one;(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;4-bromo-2-hydroxybenzoic acid;5-bromo-2-(2-hydroxypropan-2-yl)phenol;(E)-1-[4-(3-ethylphenyl)piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;(E)-4-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]but-3-en-2-one;(E)-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;methyl 4-bromo-2-hydroxybenzoate (PubChem CID 158764426) has the molecular formula C122H142Br3N5O23 and a molecular weight of 2286.20 g/mol. Its IUPAC name is (E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-(4-cyclopropyl-3-hydroxyphenyl)prop-2-en-1-one;(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;4-bromo-2-hydroxybenzoic acid;5-bromo-2-(2-hydroxypropan-2-yl)phenol;(E)-1-[4-(3-ethylphenyl)piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;(E)-4-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]but-3-en-2-one;(E)-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;methyl 4-bromo-2-hydroxybenzoate.

Molecular Properties

Compound Name(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-(4-cyclopropyl-3-hydroxyphenyl)prop-2-en-1-one;(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;4-bromo-2-hydroxybenzoic acid;5-bromo-2-(2-hydroxypropan-2-yl)phenol;(E)-1-[4-(3-ethylphenyl)piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;(E)-4-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]but-3-en-2-one;(E)-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;methyl 4-bromo-2-hydroxybenzoate
PubChem CID158764426
Molecular FormulaC122H142Br3N5O23
Molecular Weight2286.20 g/mol
Exact Mass2281.76
IUPAC Name(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-(4-cyclopropyl-3-hydroxyphenyl)prop-2-en-1-one;(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;4-bromo-2-hydroxybenzoic acid;5-bromo-2-(2-hydroxypropan-2-yl)phenol;(E)-1-[4-(3-ethylphenyl)piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;(E)-4-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]but-3-en-2-one;(E)-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;methyl 4-bromo-2-hydroxybenzoate
SMILESCC(=O)/C=C/c1ccc(C(C)(C)O)c(O)c1.CC(C)(O)c1ccc(/C=C/C(=O)N2CCC(c3cccc(CN)c3)CC2)cc1O.CC(C)(O)c1ccc(/C=C/C(=O)O)cc1O.CC(C)(O)c1ccc(Br)cc1O.CCc1cccc(C2CCN(C(=O)/C=C/c3ccc(C(C)(C)O)c(O)c3)CC2)c1.COC(=O)c1ccc(Br)cc1O.NCc1cccc(C2CCN(C(=O)/C=C/c3ccc(C4CC4)c(O)c3)CC2)c1.O=C(O)c1ccc(Br)cc1O
InChIInChI=1S/C25H31NO3.C24H30N2O3.C24H28N2O2.C13H16O3.C12H14O4.C9H11BrO2.C8H7BrO3.C7H5BrO3/c1-4-18-6-5-7-21(16-18)20-12-14-26(15-13-20)24(28)11-9-19-8-10-22(23(27)17-19)25(2,3)29;1-24(2,29)21-8-6-17(15-22(21)27)7-9-23(28)26-12-10-19(11-13-26)20-5-3-4-18(14-20)16-25;25-16-18-2-1-3-21(14-18)19-10-12-26(13-11-19)24(28)9-5-17-4-8-22(20-6-7-20)23(27)15-17;1-9(14)4-5-10-6-7-11(12(15)8-10)13(2,3)16;1-12(2,16)9-5-3-8(7-10(9)13)4-6-11(14)15;1-9(2,12)7-4-3-6(10)5-8(7)11;1-12-8(11)6-3-2-5(9)4-7(6)10;8-4-1-2-5(7(10)11)6(9)3-4/h5-11,16-17,20,27,29H,4,12-15H2,1-3H3;3-9,14-15,19,27,29H,10-13,16,25H2,1-2H3;1-5,8-9,14-15,19-20,27H,6-7,10-13,16,25H2;4-8,15-16H,1-3H3;3-7,13,16H,1-2H3,(H,14,15);3-5,11-12H,1-2H3;2-4,10H,1H3;1-3,9H,(H,10,11)/b11-9+;9-7+;9-5+;5-4+;6-4+;;;
InChIKeyIPBQWYLRESCPDA-MQPMCTMVSA-N
XLogP22.36
TPSA493.93 Ų
H-Bond Donors17
H-Bond Acceptors23
Rotatable Bonds24
Heavy Atoms153
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002286.20
LogP ≤ 522.36
H-Bond Donors ≤ 517
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-(4-cyclopropyl-3-hydroxyphenyl)prop-2-en-1-one;(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;4-bromo-2-hydroxybenzoic acid;5-bromo-2-(2-hydroxypropan-2-yl)phenol;(E)-1-[4-(3-ethylphenyl)piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;(E)-4-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]but-3-en-2-one;(E)-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;methyl 4-bromo-2-hydroxybenzoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

tert-butyl N-[[3-[1-[(E)-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-enoyl]piperidin-4-yl]phenyl]methyl]carbamate
CID 86725228
4-[3-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-oxoprop-1-enyl]-2-hydroxybenzamide
CID 67116038
(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-(3,4-dihydroxyphenyl)prop-2-en-1-one
CID 52933710
1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-[3-hydroxy-4-(hydroxymethyl)phenyl]prop-2-en-1-one
CID 123347022
1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-[3,4-dihydroxy-5-(hydroxymethyl)phenyl]prop-2-en-1-one
CID 123980055
tert-butyl N-[[3-[1-[3-(3,4-dihydroxyphenyl)prop-2-enoyl]piperidin-4-yl]phenyl]methyl]carbamate
CID 77492425
(Z)-3-(3,4-dihydroxyphenyl)-1-[4-[3-(methylaminomethyl)phenyl]piperidin-1-yl]prop-2-en-1-one
CID 90368492
2-ethyl-N-methoxy-4-[(E)-3-[4-[3-(methylaminomethyl)phenyl]piperidin-1-yl]-3-oxoprop-1-enyl]benzamide
CID 118121062
(E)-3-(3,4-dihydroxyphenyl)-1-[4-[3-(methylaminomethyl)phenyl]piperidin-1-yl]prop-2-en-1-one;ethane
CID 144547678
4-[(1E)-3-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]buta-1,3-dienyl]benzene-1,2-diol
CID 118121003
4-[2-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-2-oxoethyl]-2-hydroxybenzamide
CID 67115123
4-[3-(aminomethyl)phenyl]piperidine-1-carboxylic acid
CID 22266122

Frequently Asked Questions

What is the IUPAC name of (E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-(4-cyclopropyl-3-hydroxyphenyl)prop-2-en-1-one;(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;4-bromo-2-hydroxybenzoic acid;5-bromo-2-(2-hydroxypropan-2-yl)phenol;(E)-1-[4-(3-ethylphenyl)piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;(E)-4-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]but-3-en-2-one;(E)-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;methyl 4-bromo-2-hydroxybenzoate?
The IUPAC name of (E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-(4-cyclopropyl-3-hydroxyphenyl)prop-2-en-1-one;(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;4-bromo-2-hydroxybenzoic acid;5-bromo-2-(2-hydroxypropan-2-yl)phenol;(E)-1-[4-(3-ethylphenyl)piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;(E)-4-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]but-3-en-2-one;(E)-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;methyl 4-bromo-2-hydroxybenzoate (CID 158764426) is (E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-(4-cyclopropyl-3-hydroxyphenyl)prop-2-en-1-one;(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;4-bromo-2-hydroxybenzoic acid;5-bromo-2-(2-hydroxypropan-2-yl)phenol;(E)-1-[4-(3-ethylphenyl)piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;(E)-4-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]but-3-en-2-one;(E)-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;methyl 4-bromo-2-hydroxybenzoate.
What is the SMILES notation for (E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-(4-cyclopropyl-3-hydroxyphenyl)prop-2-en-1-one;(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;4-bromo-2-hydroxybenzoic acid;5-bromo-2-(2-hydroxypropan-2-yl)phenol;(E)-1-[4-(3-ethylphenyl)piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;(E)-4-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]but-3-en-2-one;(E)-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;methyl 4-bromo-2-hydroxybenzoate?
The canonical SMILES for (E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-(4-cyclopropyl-3-hydroxyphenyl)prop-2-en-1-one;(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;4-bromo-2-hydroxybenzoic acid;5-bromo-2-(2-hydroxypropan-2-yl)phenol;(E)-1-[4-(3-ethylphenyl)piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;(E)-4-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]but-3-en-2-one;(E)-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;methyl 4-bromo-2-hydroxybenzoate is CC(=O)/C=C/c1ccc(C(C)(C)O)c(O)c1.CC(C)(O)c1ccc(/C=C/C(=O)N2CCC(c3cccc(CN)c3)CC2)cc1O.CC(C)(O)c1ccc(/C=C/C(=O)O)cc1O.CC(C)(O)c1ccc(Br)cc1O.CCc1cccc(C2CCN(C(=O)/C=C/c3ccc(C(C)(C)O)c(O)c3)CC2)c1.COC(=O)c1ccc(Br)cc1O.NCc1cccc(C2CCN(C(=O)/C=C/c3ccc(C4CC4)c(O)c3)CC2)c1.O=C(O)c1ccc(Br)cc1O.
What is the InChIKey of (E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-(4-cyclopropyl-3-hydroxyphenyl)prop-2-en-1-one;(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;4-bromo-2-hydroxybenzoic acid;5-bromo-2-(2-hydroxypropan-2-yl)phenol;(E)-1-[4-(3-ethylphenyl)piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;(E)-4-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]but-3-en-2-one;(E)-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;methyl 4-bromo-2-hydroxybenzoate?
The InChIKey is IPBQWYLRESCPDA-MQPMCTMVSA-N. The full InChI is InChI=1S/C25H31NO3.C24H30N2O3.C24H28N2O2.C13H16O3.C12H14O4.C9H11BrO2.C8H7BrO3.C7H5BrO3/c1-4-18-6-5-7-21(16-18)20-12-14-26(15-13-20)24(28)11-9-19-8-10-22(23(27)17-19)25(2,3)29;1-24(2,29)21-8-6-17(15-22(21)27)7-9-23(28)26-12-10-19(11-13-26)20-5-3-4-18(14-20)16-25;25-16-18-2-1-3-21(14-18)19-10-12-26(13-11-19)24(28)9-5-17-4-8-22(20-6-7-20)23(27)15-17;1-9(14)4-5-10-6-7-11(12(15)8-10)13(2,3)16;1-12(2,16)9-5-3-8(7-10(9)13)4-6-11(14)15;1-9(2,12)7-4-3-6(10)5-8(7)11;1-12-8(11)6-3-2-5(9)4-7(6)10;8-4-1-2-5(7(10)11)6(9)3-4/h5-11,16-17,20,27,29H,4,12-15H2,1-3H3;3-9,14-15,19,27,29H,10-13,16,25H2,1-2H3;1-5,8-9,14-15,19-20,27H,6-7,10-13,16,25H2;4-8,15-16H,1-3H3;3-7,13,16H,1-2H3,(H,14,15);3-5,11-12H,1-2H3;2-4,10H,1H3;1-3,9H,(H,10,11)/b11-9+;9-7+;9-5+;5-4+;6-4+;;;.
What are the key properties of (E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-(4-cyclopropyl-3-hydroxyphenyl)prop-2-en-1-one;(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;4-bromo-2-hydroxybenzoic acid;5-bromo-2-(2-hydroxypropan-2-yl)phenol;(E)-1-[4-(3-ethylphenyl)piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;(E)-4-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]but-3-en-2-one;(E)-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;methyl 4-bromo-2-hydroxybenzoate?
(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-(4-cyclopropyl-3-hydroxyphenyl)prop-2-en-1-one;(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;4-bromo-2-hydroxybenzoic acid;5-bromo-2-(2-hydroxypropan-2-yl)phenol;(E)-1-[4-(3-ethylphenyl)piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;(E)-4-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]but-3-en-2-one;(E)-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;methyl 4-bromo-2-hydroxybenzoate has a molecular weight of 2286.20 g/mol, XLogP of 22.36, 24 rotatable bonds, 17 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-(4-cyclopropyl-3-hydroxyphenyl)prop-2-en-1-one;(E)-1-[4-[3-(aminomethyl)phenyl]piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;4-bromo-2-hydroxybenzoic acid;5-bromo-2-(2-hydroxypropan-2-yl)phenol;(E)-1-[4-(3-ethylphenyl)piperidin-1-yl]-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-en-1-one;(E)-4-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]but-3-en-2-one;(E)-3-[3-hydroxy-4-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;methyl 4-bromo-2-hydroxybenzoate is sourced from PubChem (CID 158764426), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).